Vor Biopharma VOR Depreciation
Depreciation at other companies
Other financials
Where this comes from
Reported directly by Vor Biopharma in its filing.
Tagged under the XBRL concept us-gaap:Depreciation.
The official record: Vor Biopharma’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vor Biopharma's depreciation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vor Biopharma's depreciation?
- Vor Biopharma (VOR) reported depreciation of $28K in Q1 2026.
- How has Vor Biopharma's depreciation changed year-over-year?
- Vor Biopharma's depreciation decreased by 96.6% year-over-year, from $825K to $28K.
- What is the long-term trend for Vor Biopharma's depreciation?
- Over 4 years (2021 to 2025), Vor Biopharma's depreciation has grown at a 20.4% compound annual growth rate (CAGR), from $1.41M to $2.95M.